AstraZeneca Common Stock Total Equity vs Total Assets Analysis

AZN Stock   10,468  100.00  0.95%   
AstraZeneca PLC financial indicator trend analysis is way more than just evaluating AstraZeneca PLC prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether AstraZeneca PLC is a good investment. Please check the relationship between AstraZeneca PLC Common Stock Total Equity and its Total Assets accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AstraZeneca PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

Common Stock Total Equity vs Total Assets

Common Stock Total Equity vs Total Assets Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of AstraZeneca PLC Common Stock Total Equity account and Total Assets. At this time, the significance of the direction appears to have weak relationship.
The correlation between AstraZeneca PLC's Common Stock Total Equity and Total Assets is 0.33. Overlapping area represents the amount of variation of Common Stock Total Equity that can explain the historical movement of Total Assets in the same time period over historical financial statements of AstraZeneca PLC, assuming nothing else is changed. The correlation between historical values of AstraZeneca PLC's Common Stock Total Equity and Total Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Common Stock Total Equity of AstraZeneca PLC are associated (or correlated) with its Total Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Assets has no effect on the direction of Common Stock Total Equity i.e., AstraZeneca PLC's Common Stock Total Equity and Total Assets go up and down completely randomly.

Correlation Coefficient

0.33
Relationship DirectionPositive 
Relationship StrengthVery Weak

Common Stock Total Equity

The total value of common stock equity held by shareholders, representing their ownership interest in the company.

Total Assets

Total assets refers to the total amount of AstraZeneca PLC assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in AstraZeneca PLC books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.
Most indicators from AstraZeneca PLC's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into AstraZeneca PLC current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AstraZeneca PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
The current year's Tax Provision is expected to grow to about 984.9 M, whereas Selling General Administrative is projected to grow to (187.2 M).
 2021 2022 2023 2024 (projected)
Interest Expense1.3B1.3B1.6B1.7B
Depreciation And Amortization4.1B5.3B4.9B5.2B

AstraZeneca PLC fundamental ratios Correlations

0.940.910.950.90.830.360.85-0.240.040.330.990.480.180.70.9-0.360.850.840.20.960.820.690.830.920.33
0.940.930.880.770.840.550.97-0.52-0.160.090.970.3-0.080.490.77-0.490.90.890.010.960.80.530.820.90.25
0.910.930.910.720.790.490.87-0.4-0.30.180.930.37-0.050.460.76-0.620.840.77-0.070.940.850.460.80.930.2
0.950.880.910.870.770.40.78-0.180.090.340.930.630.220.760.9-0.310.720.710.240.90.90.640.90.890.23
0.90.770.720.870.630.30.65-0.030.240.410.850.570.310.870.83-0.220.550.750.450.740.760.760.80.750.15
0.830.840.790.770.630.420.76-0.380.00.370.830.20.20.460.85-0.260.850.750.130.880.580.750.640.840.56
0.360.550.490.40.30.420.58-0.69-0.21-0.160.36-0.04-0.260.170.2-0.370.310.580.050.380.470.190.440.42-0.09
0.850.970.870.780.650.760.58-0.67-0.25-0.150.90.22-0.310.340.63-0.530.860.86-0.120.890.760.340.780.810.11
-0.24-0.52-0.4-0.18-0.03-0.38-0.69-0.670.510.56-0.340.370.710.290.00.55-0.45-0.510.53-0.36-0.230.15-0.37-0.310.1
0.04-0.16-0.30.090.240.0-0.21-0.250.510.38-0.080.490.660.610.270.82-0.23-0.10.7-0.10.020.450.03-0.120.19
0.330.090.180.340.410.37-0.16-0.150.560.380.220.230.920.560.570.180.150.080.50.250.060.770.110.340.64
0.990.970.930.930.850.830.360.9-0.34-0.080.220.420.050.590.86-0.440.890.840.080.970.810.60.840.910.3
0.480.30.370.630.570.2-0.040.220.370.490.230.420.350.750.530.230.120.170.430.360.730.350.510.37-0.18
0.18-0.08-0.050.220.310.2-0.26-0.310.710.660.920.050.350.60.490.54-0.03-0.090.660.08-0.020.690.010.140.6
0.70.490.460.760.870.460.170.340.290.610.560.590.750.60.790.190.260.430.710.510.660.770.660.520.18
0.90.770.760.90.830.850.20.630.00.270.570.860.530.490.79-0.060.710.60.40.850.670.830.770.790.54
-0.36-0.49-0.62-0.31-0.22-0.26-0.37-0.530.550.820.18-0.440.230.540.19-0.06-0.44-0.450.54-0.42-0.360.1-0.31-0.460.22
0.850.90.840.720.550.850.310.86-0.45-0.230.150.890.12-0.030.260.71-0.440.8-0.150.950.570.460.580.860.5
0.840.890.770.710.750.750.580.86-0.51-0.10.080.840.17-0.090.430.6-0.450.80.080.820.660.560.610.830.2
0.20.01-0.070.240.450.130.05-0.120.530.70.50.080.430.660.710.40.54-0.150.080.010.190.590.14-0.010.15
0.960.960.940.90.740.880.380.89-0.36-0.10.250.970.360.080.510.85-0.420.950.820.010.770.580.770.940.41
0.820.80.850.90.760.580.470.76-0.230.020.060.810.73-0.020.660.67-0.360.570.660.190.770.40.80.75-0.15
0.690.530.460.640.760.750.190.340.150.450.770.60.350.690.770.830.10.460.560.590.580.40.480.620.56
0.830.820.80.90.80.640.440.78-0.370.030.110.840.510.010.660.77-0.310.580.610.140.770.80.480.730.08
0.920.90.930.890.750.840.420.81-0.31-0.120.340.910.370.140.520.79-0.460.860.83-0.010.940.750.620.730.38
0.330.250.20.230.150.56-0.090.110.10.190.640.3-0.180.60.180.540.220.50.20.150.41-0.150.560.080.38
Click cells to compare fundamentals

AstraZeneca PLC Account Relationship Matchups

AstraZeneca PLC fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets61.4B66.7B105.4B96.5B101.1B106.2B
Short Long Term Debt Total18.2B20.4B30.8B29.2B28.6B30.1B
Other Current Liab12.9B14.4B16.0B16.3B19.8B20.8B
Total Current Liabilities18.1B20.3B22.6B26.3B30.5B32.1B
Total Stockholder Equity13.1B15.6B39.3B37.0B39.1B41.1B
Property Plant And Equipment Net8.3B8.9B10.2B9.4B10.5B6.8B
Net Debt12.9B12.5B24.5B23.1B22.8B23.9B
Retained Earnings2.8B5.3B1.7B(574M)4.5B8.5B
Accounts Payable1.8B2.4B2.8B2.6B3.3B2.8B
Cash5.4B7.8B6.3B6.2B5.8B4.7B
Non Current Assets Total45.8B47.2B79.1B73.9B76.1B79.9B
Non Currrent Assets Other1.7B1.1B1.1B1.1B5.6B5.9B
Cash And Short Term Investments6.2B8.0B6.4B6.4B5.9B5.8B
Net Receivables3.6B3.8B6.0B7.2B8.4B8.8B
Common Stock Shares Outstanding1.3B1.3B1.4B1.6B1.6B1.4B
Liabilities And Stockholders Equity61.4B66.7B105.4B96.5B101.1B106.2B
Non Current Liabilities Total28.7B30.8B43.5B33.1B31.4B33.0B
Inventory3.2B4.0B9.0B4.7B5.4B5.7B
Other Current Assets2.6B3.7B4.8B4.4B5.4B5.2B
Total Liab46.8B51.1B66.1B59.4B62.0B65.1B
Property Plant And Equipment Gross8.3B8.9B10.2B9.4B19.1B20.1B
Total Current Assets15.6B19.5B26.2B22.6B25.1B15.3B
Short Term Debt2.0B2.4B2.9B6.5B5.4B5.7B
Other Assets3.5B4.3B5.3B4.2B4.8B5.0B
Other Stockholder Equity7.8B8.0B35.1B33.5B33.3B35.0B
Accumulated Other Comprehensive Income(143M)881M111M(1.6B)(949M)(996.5M)
Intangible Assets20.8B20.9B42.4B39.3B38.1B40.0B
Other Liab10.3B10.5B13.0B8.5B9.8B6.7B
Long Term Debt15.7B17.5B28.1B23.0B22.4B11.3B
Good Will11.7B11.8B20.0B19.8B20.0B21.1B
Property Plant Equipment8.3B8.9B10.2B9.4B10.9B7.9B
Net Tangible Assets(19.4B)(17.2B)(23.1B)(22.1B)(19.9B)(20.9B)
Short Long Term Debt1.8B2.2B1.7B5.3B5.1B5.4B
Capital Surpluse4.4B4.4B7.9B8.0B9.2B6.4B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in AstraZeneca Stock

Balance Sheet is a snapshot of the financial position of AstraZeneca PLC at a specified time, usually calculated after every quarter, six months, or one year. AstraZeneca PLC Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of AstraZeneca PLC and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which AstraZeneca currently owns. An asset can also be divided into two categories, current and non-current.